Marwyn Value Investors (MVI) Competitors

6.6% of Marwyn Value Investors shares are owned by institutional investors. Comparatively, 8.5% of Baillie Gifford Shin Nippon shares are owned by institutional investors. 1.4% of Marwyn Value Investors shares are owned by insiders. Comparatively, 0.2% of Baillie Gifford Shin Nippon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Marwyn Value Investors has higher revenue and earnings than Baillie Gifford Shin Nippon. Marwyn Value Investors is trading at a lower price-to-earnings ratio than Baillie Gifford Shin Nippon, indicating that it is currently the more affordable of the two stocks.

Marwyn Value Investors has a net margin of 765.94% compared to Baillie Gifford Shin Nippon's net margin of 101.98%. Marwyn Value Investors' return on equity of 27.99% beat Baillie Gifford Shin Nippon's return on equity.

In the previous week, Marwyn Value Investors' average media sentiment score of 0.00 equaled Baillie Gifford Shin Nippon'saverage media sentiment score.

Marwyn Value Investors pays an annual dividend of GBX 9.06 per share and has a dividend yield of 6.6%. Baillie Gifford Shin Nippon pays an annual dividend of GBX 0.60 per share and has a dividend yield of 0.4%. Marwyn Value Investors pays out 13.1% of its earnings in the form of a dividend. Baillie Gifford Shin Nippon pays out 12.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Marwyn Value Investors has a beta of 0.254, suggesting that its share price is 75% less volatile than the broader market. Comparatively, Baillie Gifford Shin Nippon has a beta of 0.92498237, suggesting that its share price is 8% less volatile than the broader market.

Marwyn Value Investors has a beta of 0.254, suggesting that its share price is 75% less volatile than the broader market. Comparatively, Baillie Gifford European Growth Trust has a beta of 1.3782868, suggesting that its share price is 38% more volatile than the broader market.

Marwyn Value Investors pays an annual dividend of GBX 9.06 per share and has a dividend yield of 6.6%. Baillie Gifford European Growth Trust pays an annual dividend of GBX 0.72 per share and has a dividend yield of 0.7%. Marwyn Value Investors pays out 13.1% of its earnings in the form of a dividend. Baillie Gifford European Growth Trust pays out 52.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Marwyn Value Investors is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Baillie Gifford European Growth Trust had 4 more articles in the media than Marwyn Value Investors. MarketBeat recorded 4 mentions for Baillie Gifford European Growth Trust and 0 mentions for Marwyn Value Investors. Baillie Gifford European Growth Trust's average media sentiment score of 1.92 beat Marwyn Value Investors' score of 0.00 indicating that Baillie Gifford European Growth Trust is being referred to more favorably in the news media.

6.6% of Marwyn Value Investors shares are owned by institutional investors. Comparatively, 4.1% of Baillie Gifford European Growth Trust shares are owned by institutional investors. 1.4% of Marwyn Value Investors shares are owned by insiders. Comparatively, 0.3% of Baillie Gifford European Growth Trust shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Baillie Gifford European Growth Trust has lower revenue, but higher earnings than Marwyn Value Investors. Marwyn Value Investors is trading at a lower price-to-earnings ratio than Baillie Gifford European Growth Trust, indicating that it is currently the more affordable of the two stocks.

Marwyn Value Investors has a net margin of 765.94% compared to Baillie Gifford European Growth Trust's net margin of 62.35%. Marwyn Value Investors' return on equity of 27.99% beat Baillie Gifford European Growth Trust's return on equity.

In the previous week, Marwyn Value Investors' average media sentiment score of 0.00 equaled International Biotechnology'saverage media sentiment score.

Marwyn Value Investors has a beta of 0.254, suggesting that its share price is 75% less volatile than the broader market. Comparatively, International Biotechnology has a beta of 0.52431154, suggesting that its share price is 48% less volatile than the broader market.

6.6% of Marwyn Value Investors shares are held by institutional investors. Comparatively, 6.9% of International Biotechnology shares are held by institutional investors. 1.4% of Marwyn Value Investors shares are held by company insiders. Comparatively, 1.1% of International Biotechnology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Marwyn Value Investors pays an annual dividend of GBX 9.06 per share and has a dividend yield of 6.6%. International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 3.1%. Marwyn Value Investors pays out 13.1% of its earnings in the form of a dividend. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Marwyn Value Investors is clearly the better dividend stock, given its higher yield and lower payout ratio.

Marwyn Value Investors has a net margin of 765.94% compared to International Biotechnology's net margin of 82.27%. Marwyn Value Investors' return on equity of 27.99% beat International Biotechnology's return on equity.

International Biotechnology has higher revenue and earnings than Marwyn Value Investors. Marwyn Value Investors is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks.

In the previous week, Marwyn Value Investors' average media sentiment score of 0.00 equaled CT Global Managed Portfolio Growth'saverage media sentiment score.

6.6% of Marwyn Value Investors shares are owned by institutional investors. Comparatively, 0.6% of CT Global Managed Portfolio Growth shares are owned by institutional investors. 1.4% of Marwyn Value Investors shares are owned by company insiders. Comparatively, 0.1% of CT Global Managed Portfolio Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Marwyn Value Investors has a net margin of 765.94% compared to CT Global Managed Portfolio Growth's net margin of 0.00%. Marwyn Value Investors' return on equity of 27.99% beat CT Global Managed Portfolio Growth's return on equity.

Marwyn Value Investors has higher revenue and earnings than CT Global Managed Portfolio Growth. Marwyn Value Investors is trading at a lower price-to-earnings ratio than CT Global Managed Portfolio Growth, indicating that it is currently the more affordable of the two stocks.